Pituitary & hypothalamus

Natural history of conservatively managed nonfunctioning pituitary macroadenomas in the elderly: A study from the Swedish Pituitary Registry

PituitaryPublished Registry-based cohort study

Authors' conclusion

Pituitary surgery was uncommon in conservatively managed elderly patients with macro-NFPAs. Baseline visual field defects, but not tumour size, were associated with subsequent surgery

Study context

Population
Patients ≥ 65 years in the Swedish Pituitary Registry diagnosed 1991–2023 with macro-NFPA and a decision for conservative management; 38% females38% females
Participants
673 patients
Exposure
65-72 vs 73-80 vs ≥ 81
Outcome
Adenoma progression, pituitary function, visual impairment and later surgery
Follow-up
1- and 5-year ; surgery up to 7.5 years
Methodological detailsnational registry, conservatively managed
  • National registry
  • Conservatively managed

Main finding

As reported in the abstract

Underwent surgery during follow-up
6.7%
Later surgery associated with visual field defects at diagnosis (regression)
p < 0.05

Observational data: associations, not effects.

Further findings

Hormone deficiencies by sex at diagnosis

P < 0.01

Baseline characteristics at diagnosis

Mean age (years)
76
Females older
P < 0.001
Mean adenoma diameter (mm)
20
Mean adenoma volume (mm³)
3067
Visual field defects
20%
Reduced visual acuity
12%
No sex differences in visual impairment

Age gradient at diagnosis

Hormone deficiencies and visual impairments increased with age
P < 0.001
Oldest subgroup had the largest adenomas
P < 0.01
In oldest subgroup, females had larger tumours
P < 0.05
In oldest subgroup, males had more deficiencies
P < 0.05

Original publication

Natural history of conservatively managed nonfunctioning pituitary macroadenomas in the elderly: A study from the Swedish Pituitary Registry. Pituitary. Published 20 August 2026. doi:10.1007/s11102-026-01752-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.